Anticoronavirals: the development of COVID-19 therapies and the challenges that remain : vimarsana.com

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

Related Keywords

United States , Japan , Viacheslav Lopatin Shutterstock , National Institutes Of Health , Drug Administration , Melinda Gates Foundation , Treatment Guidelines Panel , Nature Microbiology , Middle East , National Institutes , Emergency Use Authorization , United States Food , Therapeutics Accelerator , Coronavirus Disease Covid 19 , Ovid 19 , Ntibodies , Ntibody , Oronavirus , Rugs , Fficacy , Mmunity , Inase , Icrobiology , Onoclonal Antibody , Ortality , Andemic , Emdesivir , Esearch , Espiratory , Ars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Mall Molecules , Yndrome , Herapeutics , Accine ,